Journal of Shandong University (Health Sciences) ›› 2018, Vol. 56 ›› Issue (10): 1-2.doi: 10.6040/j.issn.1671-7554.0.2018.1065

   

Development of tumor biomarkers in the age of precision medicine

WANG Hongyang   

  1. Eastern Hepatobiliary Surgery Hospital of Navy Medical University, Shanghai 200438, China
  • Received:2018-09-13 Published:2022-09-27

Key words: Tumor biomarkers, Precision medicine, Early diagnosis

CLC Number: 

  • R446.11
[1] Linlin WANG,Yuping SUN. From the perspective of clinicians: the application and reflection of artificial intelligence in cancer precision diagnosis and treatment [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 89-96.
[2] Jun YANG. Medico-engineering cooperation: a strategic plateau of neurosurgery innovation and development in the era of precision medicine [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 83-88.
[3] Chuanxin WANG. Liquid biopsy of tumor [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 64-71.
[4] LIU Xin-nong, ZHAN Han-xiang, HU San-yuan, ZHANG Guang-yong, WANG Lei . The role of serum miR-146a in early diagnosis of sepsis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(9): 92-94.
[5] . Natriuretic peptide in early diagnosis of acute myocardial 
infarction: an experimental study in rats
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(9): 40-43.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!